Newsfeeds - Spark Newswire

1 minute read

News

Guardant Health Reports Receives Medicare Coverage For Its Guardant360 TissueNext Test

Today, 9:39 AM

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), has conveyed coverage for

32 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 9:39 AM

On Monday, 524 stocks hit new 52-week lows.

AAL

1 minute read

Wells Fargo Maintains Overweight on Guardant Health, Lowers Price Target to $115

By Benzinga Newsdesk

Today, 9:39 AM

Wells Fargo analyst Dan Leonard maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $150 to $115.

1 minute read

10 Biggest Price Target Changes For Thursday

By Lisa Levin

Today, 9:39 AM

SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading.

BBWI

4 minute read

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development

By Shanthi Rexaline

Today, 9:39 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase 2b/3 Study

AKBA

15 minute read

Earnings Scheduled For February 23, 2022

By Benzinga Insights

Today, 9:39 AM

Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter.

AAN

4 minute read

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow

By Shanthi Rexaline

Today, 9:39 AM

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.

ABCL